Annual Debt To Equity
1.11
+0.51+85.00%
December 31, 2022
Summary
- As of February 10, 2025, RVLP annual debt to equity ratio is 1.11, with the most recent change of +0.51 (+85.00%) on December 31, 2022.
- During the last 3 years, RVLP annual debt to equity has fallen by -1.23 (-52.56%).
Performance
RVLP Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Debt To Equity
3.54
+2.11+147.55%
June 30, 2023
Summary
- As of February 10, 2025, RVLP quarterly debt to equity ratio is 3.54, with the most recent change of +2.11 (+147.55%) on June 30, 2023.
- Over the past year, RVLP quarterly debt to equity has increased by +2.80 (+378.38%).
Performance
RVLP Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
RVLP Debt To Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +85.0% | +378.4% |
3 y3 years | -52.6% | +72.7% |
5 y5 years | +50.0% | +365.8% |
RVLP Debt To Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -45.9% | at high | -83.1% |
5 y | 5-year | -52.6% | -45.9% | at high | -84.5% |
alltime | all time | -52.6% | -45.9% | at high | -84.5% |
RVL Pharmaceuticals Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | 3.54(+147.6%) |
Mar 2023 | - | 1.43(+28.8%) |
Dec 2022 | 1.11(+85.0%) | 1.11(+35.4%) |
Sep 2022 | - | 0.82(+10.8%) |
Jun 2022 | - | 0.74(+10.4%) |
Mar 2022 | - | 0.67(+11.7%) |
Dec 2021 | 0.60(-74.4%) | 0.60(+9.1%) |
Sep 2021 | - | 0.55(-82.5%) |
Jun 2021 | - | 3.14(+21.7%) |
Mar 2021 | - | 2.58(+10.3%) |
Dec 2020 | 2.34 | 2.34(+60.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | 1.46(-28.8%) |
Jun 2020 | - | 2.05(+9.6%) |
Mar 2020 | - | 1.87(-20.1%) |
Dec 2019 | 2.34(+234.3%) | 2.34(+23.8%) |
Sep 2019 | - | 1.89(+81.7%) |
Jun 2019 | - | 1.04(+48.6%) |
Mar 2019 | - | 0.70(0.0%) |
Dec 2018 | 0.70(-5.4%) | 0.70(-7.9%) |
Sep 2018 | - | 0.76(0.0%) |
Jun 2018 | - | 0.76(+2.7%) |
Dec 2017 | 0.74(+4.2%) | 0.74 |
Dec 2016 | 0.71 | - |
FAQ
- What is RVL Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual debt to equity year-on-year change?
- What is RVL Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly debt to equity year-on-year change?
What is RVL Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of RVLP is 1.11
What is the all time high annual debt to equity for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual debt to equity ratio is 2.34
What is RVL Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, RVLP annual debt to equity ratio has changed by +0.51 (+85.00%)
What is RVL Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of RVLP is 3.54
What is the all time high quarterly debt to equity for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly debt to equity ratio is 3.54
What is RVL Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, RVLP quarterly debt to equity ratio has changed by +2.80 (+378.38%)